These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30109001)

  • 1. Identification of potent catalytic inhibitors of human DNA topoisomerase II by structure-based virtual screening.
    Dong G; Wu Y; Sun Y; Liu N; Wu S; Zhang W; Sheng C
    Medchemcomm; 2018 Jul; 9(7):1142-1146. PubMed ID: 30109001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.
    Matias-Barrios VM; Radaeva M; Song Y; Alperstein Z; Lee AR; Schmitt V; Lee J; Ban F; Xie N; Qi J; Lallous N; Gleave ME; Cherkasov A; Dong X
    Front Oncol; 2020; 10():633142. PubMed ID: 33598437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of New Catalytic Topoisomerase II Inhibitors as an Anti-Cancer Therapy.
    Matias-Barrios VM; Radaeva M; Ho CH; Lee J; Adomat H; Lallous N; Cherkasov A; Dong X
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azatoxin derivatives with potent and selective action on topoisomerase II.
    Leteurtre F; Sackett DL; Madalengoitia J; Kohlhagen G; MacDonald T; Hamel E; Paull KD; Pommier Y
    Biochem Pharmacol; 1995 May; 49(9):1283-90. PubMed ID: 7763310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles.
    Lee CH; Hsieh MY; Hsin LW; Chen HC; Lo SC; Fan JR; Chen WR; Chen HW; Chan NL; Li TK
    Biochem Pharmacol; 2012 May; 83(9):1208-16. PubMed ID: 22306066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular determinants of response to topoisomerase II inhibitors].
    Lansiaux A; Pourquier P
    Bull Cancer; 2011 Nov; 98(11):1299-310. PubMed ID: 22023806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of mono- and disubstituted 1H-pyrazolo[3,4]pyrimidines and 9H-purines as catalytic inhibitors of human DNA topoisomerase IIα.
    Pogorelčnik B; Brvar M; Žegura B; Filipič M; Solmajer T; Perdih A
    ChemMedChem; 2015 Feb; 10(2):345-59. PubMed ID: 25522133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flow cytometry-based method for a high-throughput analysis of drug-stabilized topoisomerase II cleavage complexes in human cells.
    de Campos-Nebel M; Palmitelli M; González-Cid M
    Cytometry A; 2016 Sep; 89(9):852-60. PubMed ID: 27517472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine.
    Marshall KM; Matsumoto SS; Holden JA; Concepción GP; Tasdemir D; Ireland CM; Barrows LR
    Biochem Pharmacol; 2003 Aug; 66(3):447-58. PubMed ID: 12907244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents.
    Khan QA; Kohlhagen G; Marshall R; Austin CA; Kalena GP; Kroth H; Sayer JM; Jerina DM; Pommier Y
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12498-503. PubMed ID: 14523238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy.
    Matias-Barrios VM; Dong X
    Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.
    Dong G; Sheng C; Wang S; Miao Z; Yao J; Zhang W
    J Med Chem; 2010 Nov; 53(21):7521-31. PubMed ID: 20942490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
    Mirault ME; Boucher P; Tremblay A
    Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast.
    Keller BA; Patel S; Fisher LM
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):329-39. PubMed ID: 9164874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.
    Dal Ben D; Palumbo M; Zagotto G; Capranico G; Moro S
    Curr Pharm Des; 2007; 13(27):2766-80. PubMed ID: 17897022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIα.
    Bergant K; Janežič M; Valjavec K; Sosič I; Pajk S; Štampar M; Žegura B; Gobec S; Filipič M; Perdih A
    Eur J Med Chem; 2019 Aug; 175():330-348. PubMed ID: 31096154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
    Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
    Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
    Park S; Thapa Magar TB; Kadayat TM; Lee HJ; Bist G; Shrestha A; Lee ES; Kwon Y
    Eur J Med Chem; 2017 Feb; 127():318-333. PubMed ID: 28068603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.
    Yi JM; Zhang XF; Huan XJ; Song SS; Wang W; Tian QT; Sun YM; Chen Y; Ding J; Wang YQ; Yang CH; Miao ZH
    Oncotarget; 2015 Apr; 6(11):8960-73. PubMed ID: 25840421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.